Abstract Objective To investigate the expression and possible roles of Wnt inhibitory factor-1 (Wif-1) and β-catenin in the Wnt pathway in childhood acute lymphoblastic leukemia (ALL). Methods The clinical data of 35 children who had newly-diagnosed ALL and achieved complete remission on day 33 of remission induction therapy were retrospectively reviewed. The children before treatment were considered as the incipient group, and those who achieved complete remission on day 33 were considered as the remission group. Fifteen children with non-malignant hematologic diseases were enrolled as the control group. RT-PCR was used to measure the mRNA expression of Wif-1 and β-catenin. ELISA was used to measure the protein expression of Wif-1. Results Compared with the control and remission groups, the incipient group had significantly lower mRNA and protein expression of Wif-1 and significantly higher mRNA expression of β-catenin (P < 0.05). In the incipient and remission groups, high-risk children showed significantly higher mRNA expression of β-catenin and significantly lower mRNA and protein expression of Wif-1 than the medium- and low-risk children (P < 0.05). In the incipient and remission group, the children with T-cell acute lymphoblastic leukemia showed significantly higher mRNA expression of β-catenin and significantly lower mRNA and protein expression of Wif-1 compared with those with B-lineage acute lymphoblastic leukemia (P < 0.05). In each group, there was a negative correlation between the mRNA expression of Wif-1 and β-catenin (P < 0.05). Conclusions Reduced expression of Wif-1 and increased expression of β-catenin may be involved in the pathogenesis of childhood ALL, and the degree of reduction in Wif-1 and/or increase in β-catenin may be related to prognosis.
GAO Ji-Zhao,ZHAO Ji-Ou,TAN Ying. Expression of Wif-1 and β-catenin in the Wnt pathway in childhood acute lymphoblastic leukemia[J]. CJCP, 2016, 18(9): 835-839.
GAO Ji-Zhao,ZHAO Ji-Ou,TAN Ying. Expression of Wif-1 and β-catenin in the Wnt pathway in childhood acute lymphoblastic leukemia[J]. CJCP, 2016, 18(9): 835-839.
Kuo FC, Wang SM, Shen CF, et al. Bloodstream infections in pediatric patients with acute leukemia:Emphasis on gramnegative bacteria infections[J]. J Microbiol Immunol Infect, 2015, 103(17):1033-1039.
[2]
Wang R, Geng N, Zhou Y, et al. Aberrant Wnt-1/beta-catenin signaling and WIF-1 deficiency are important events which promote tumor cell invasion and metastasis in salivary gland adenoid cystic carcinoma[J]. Biomed Mater Eng, 2015, 26(Suppl 1):S2145-2153.
[3]
Mitsui Y, Yasumoto H, Nagami T, et al. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1(Wif-1) is associated with pathogenesis of adrenocortical tumor[J]. Oncotarget, 2014, 5(8):2198-2207.
Zhang J, Zhou B, Liu Y, et al. Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma[J]. Cancer Lett, 2014, 348(1-2):12-19.
Liepinsh E, Bányai L, Patthy L, et al. NMR structure of the WIF domain of the human Wnt-inhibitory factor-1[J]. J Mol Biol, 2006, 357(3):942-950.
[12]
Xu JH, Yang HP, Zhou XD, et al. Role of Wnt inhibitory factor-1 in inhibition of Bisdemethoxycurcumin mediated epithelial-tomesenchymal transition in highly metastatic lung cancer 95D cells[J]. Chin Med J (Engl), 2015, 128(10):1376-1383.
Roman-Gomez J, Jimenez-Velasco A, Agirre X, et al. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis[J]. J Clin Oncol, 2005, 23(28):7043-7049.